A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
Pharmacologic Treatment of Childhood Migraine
J Pediatr 120:653-657, Ingarashi,M.,et al, 1992
Chronic Daily Headache
Neurol 42:32-36, Sheftell,F.D., 1992
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg/day) in Pats. After a TIA or Minor Ischemic Stroke
Dutch TIA Trial Study Group, NEJM 325:1261-1266, 1303991., , 1991
Swedish Aspirin Low-Dose Trial (SALT) of 75 mg Aspirin as Secondary Prophylaxis After Cerebrovascular Ischaemic Events
The SALT Coll Group, Lancet 338:1345-13491991., , 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation:A Review of Prospective Randomized Trials
Ann Neurol 30:511-518, Albers,G.W.,et al, 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation
Ann Int Med 115:727-736, Albers,G.W.,et al, 1991
Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991
Stroke Prevention in Women:role of Aspirin Versus Ticlopidine
Am J Med 91:288-292, Hershey,L.A., 1991
Diagnosis and Treatment of Ischemic Stroke
JAMA 266:2413-2418, Caplan,L.R., 1991
Erythromelalgia:Review of Clinical Characteristics and Pathophysiology
Am J Med 91:416-422, Jurzrock,R.&Cohen,P.R., 1991
Adult Reye's Syndrome:A Review with New Evidence for a Generalized Defect in Intramitochondrial Enzyme Processing
Neurol 41:1815-1821, VanCoster,R.N.,et al, 1991
Ticlopidine
Editorial, Lancet 337:459-4601991., , 1991
Thrombotic Thrombocytopenic Purpura Related to Ticlopidine
Lancet 337:774-776, Page,Y.,et al, 1991
Aspirin in the Prevention of Thrombosis
Medicine 70:161-178, Lekstrom,J.A.&Bell,W.R., 1991
The European Stroke Prevention Study:Results According to Sex
Neurol 41:1189-1192, Sivenius,J.,et al, 1991
Antiphospholipid Antibodies in Cerebral Ischemia
Stroke 22:750-753, Montalban,J.,et al, 1991
Ticlopidine and Thrombocytopenia
NEJM 323:1487-1489, Takishita,S.,et al, 1990
Low-Dose Aspirin for Migraine Prophylaxis
JAMA 264:1711-1713, 17211990., Burning,J.E.,et al, 1990
Management Dilemmas in Carotid Artery Disease
Patient Care 24:14-46, Adams,H.P.,et al, 1990
Aspirin and Stroke
Arch Neurol 47:1353-1354, Buring,J.E.,et al, 1990
The Physician's Health Study, A Neurologist's Concern
Arch Neurol 47:1352-1354, Jonas,S., 1990
Mechanism of Stroke in Patients Taking Aspirin
Neurol 40:1682-1685, Chimowitz,M.I.,et al, 1990
Ticlopidine, A New Antithrombotic Drug:But Is It Better than Aspirin for Longterm Use?
JNNP 53:185-187, Warlow,C., 1990
European Stroke Prevention Study
ESPS Group, Stroke 21:1122-11301990., , 1990
Current Management of Amaurosis Fugax
The Amaurosis Fugax Study Group, Stroke 21:201-2081990., , 1990
Preliminary Report of the Stroke Prevention in Atrial Fibrillation Study
Study Group, NEJM 322:863-8681990., , 1990
Combination Therapy with Low-Dose Aspirin and Ticlopidine in Cerebral Ischemia
Stroke 20:1643-1647, Uchiyama,S.,et al, 1989
The Canadian American Ticlopidine Study (CATS) in Thromboembolic Stroke
Lancet 1:1215-1220, Gent,M.,et al, 1989
A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients
NEJM 321:501-507, Hass,W.H.,et al, 1989
A Randomized Trial of Aspirin or Heparin in Hospitalized Patients with Recent Transient Ischemic Attacks:A Pilot Study
Stroke 20:441-447, Biller,J.,et al, 1989
Intracranial Branch Atheromatous Disease:A Neglected, Understudied, and Underused Concept
Neurol 39:1246-1250, Caplan,L.R., 1989
Aseptic Meningitis Complicating Adult Kawasaki Disease:Case Report and Review of the Literature
Am J Med 87:106-110, McIlroy,M.A.,et al, 1989
Sex Difference in Antithrombotic Effect of Aspirin
Stroke 20:34-37, Spranger,M.,et al, 1989
Placebo-Controlled, Randomised Trial of Warfarin & ASA for Prevention of Thromboembolic Complic in Chronic A Fib
Lancet 1:175-179, Petersen,P.,et al, 1989
Management of Carotid Artery Occlusion
Stroke 20:123-126, Cote,R.&Caron,J., 1989
Indium-111-Labeled Platelet Scintigraphy in Carotid Atherosclerosis
Stroke 20:27-33, Minar,E.,et al, 1989
Amaurosis Fugax Associated with Antiphospholipid Antibodies
Ann Neurol 25:228-232, Digre,K.B.,et al, 1989
Aspirin for Strokes and Transient Ischaemic Attacks
BMJ 297:995-996, Sandercock,P., 1988
Reye's Syndrome and Aspirin, Evidence for a Dose-Response Effect
JAMA 260:657-661, Pinsky,P.F.,et al, 1988
Aspirin All Round
BMJ 296:307-308, Orme,M., 1988
Preliminary Report:Findings from the Aspirin Component of the Ongoing Physicians'Health Study
The Steering Comm. , NEJM 318:262-264, 245-24688., , 1988
Randomized Trial of Prophylactic Daily Aspirin in British Male Doctors
BMJ 296:313-316, Peto,R.,et al, 1988
Secondary Prevention of Vascular Disease by Prolonged Antiplatelet Treatment
Antiplatelet Trailists'Collaboration, BMJ 296:320-3311988., , 1988
Medical Treatment of Transient Ischemic Attacks:Does it Influence Mortality
Stroke 19:397-400, Ramirez-Lassepas,M.&Cipolle,R.J., 1988
Macular Hemorrhage in the Aging Eye:The Effects of Anticoagulants
NEJM 318:1126-1127, Kingham,J.D.,et al, 1988
Clinical Valproate Toxicity Induced by Acetylsalicylic Acid
Neurol 37:1392-1394, Goulden,K.J.,et al, 1987
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987
The European Stroke Prevention Study (ESPS) Principal End-Points
The ESPS Group, Lancet 2:1351-13541987., , 1987